| Financial Year |
March 31 2023 |
| Monetary Funds |
9,865,744,047.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,269,675.87 |
| Accounts Receivable |
3,798,188,850.77 |
| Advances to Suppliers |
263,121,468.98 |
| Other Receivables |
9,406,734.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,635,599,579.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
213,558,911.31 |
| Total Current Assets |
16,792,889,268.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
7,502,051.21 |
| Investment Properties |
712,043,216.83 |
| Fixed Assetes |
14,954,811,317.75 |
| Under-construction Projects |
2,455,462,548.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,261,367,318.19 |
| R&D expenses |
-- |
| Goodwill |
20,406,065.22 |
| Long-Term Deferred and Prepaid Expenses |
6,517,328.76 |
| Deferred Income Tax Assets |
163,058,855.29 |
| Other Non-Current Assets |
235,795,567.85 |
| Sub-Total of Non-Current Assets |
21,367,665,879.70 |
| Total Assets |
38,160,555,147.99 |
| Short-Term Loans |
3,745,920,180.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,491,269,627.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
883,089,567.27 |
| Taxes Payable |
244,033,342.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,463,922,676.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
33,652,742.12 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
8,900,219,600.28 |
| Long-term Loans |
171,903,354.93 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
382,303,486.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
870,956,151.82 |
| Total Liabilities |
9,771,175,752.10 |
| Paid-In Capital(Or Share Stock) |
2,321,155,816.00 |
| Capital Surplus |
12,707,541,713.49 |
| Surplus Reserve |
1,113,838,258.48 |
| LESS:Treasury Stock |
128,133,360.00 |
| Undistributed Profits |
12,295,470,552.32 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
28,389,379,395.89 |
| Owner's Equity（Stockholder's Equity） |
28,389,379,395.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
38,160,555,147.99 |
